These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16455109)

  • 61. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.
    Miller DS
    Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1.
    Wesołowska O
    Acta Biochim Pol; 2011; 58(4):433-48. PubMed ID: 22187677
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolism of dietary polyphenols and possible interactions with drugs.
    Lambert JD; Sang S; Lu AY; Yang CS
    Curr Drug Metab; 2007 Jun; 8(5):499-507. PubMed ID: 17584021
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transporter-mediated natural product-drug interactions for the treatment of cardiovascular diseases.
    Zha W
    J Food Drug Anal; 2018 Apr; 26(2S):S32-S44. PubMed ID: 29703385
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plant flavonoids--biosynthesis, transport and involvement in stress responses.
    Petrussa E; Braidot E; Zancani M; Peresson C; Bertolini A; Patui S; Vianello A
    Int J Mol Sci; 2013 Jul; 14(7):14950-73. PubMed ID: 23867610
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.
    Jiang W; Hu M
    RSC Adv; 2012 Sep; 2(21):7948-7963. PubMed ID: 25400909
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Disposition of flavonoids impacts their efficacy and safety.
    Ma Y; Zeng M; Sun R; Hu M
    Curr Drug Metab; 2014; 15(9):841-64. PubMed ID: 25658129
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Flavonoids for reduction of atherosclerotic risk.
    Maron DJ
    Curr Atheroscler Rep; 2004 Jan; 6(1):73-8. PubMed ID: 14662111
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Flavonoids as drugs at the small intestinal level.
    Wenzel U
    Curr Opin Pharmacol; 2013 Dec; 13(6):864-8. PubMed ID: 24094625
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is Intake of Flavonoid-Based Food Supplements During Pregnancy Safe for the Developing Child? A Literature Review.
    Barenys M; Masjosthusmann S; Fritsche E
    Curr Drug Targets; 2017; 18(2):196-231. PubMed ID: 26240050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of hepatic Mrp2 in the interaction of flavopiridol and bilirubin: impact on therapy.
    Jäger W; Gehring E; Hagenauer B; Aust S; Senderowicz A; Thalhammer T
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):610-1. PubMed ID: 14692715
    [No Abstract]   [Full Text] [Related]  

  • 72. Research trends in flavonoids and health.
    Perez-Vizcaino F; Fraga CG
    Arch Biochem Biophys; 2018 May; 646():107-112. PubMed ID: 29580946
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Flavonoids - Clinical effects and applications in dentistry: A review.
    Sankari SL; Babu NA; Rani V; Priyadharsini C; Masthan KM
    J Pharm Bioallied Sci; 2014 Jul; 6(Suppl 1):S26-9. PubMed ID: 25210379
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.
    Galluzzo P; Marino M
    Genes Nutr; 2006 Sep; 1(3-4):161-76. PubMed ID: 18850212
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ABCA8: A potential therapeutic target in the treatment of colorectal cancer?
    Dong DB; Shao HJ
    Dig Liver Dis; 2024 May; 56(5):903. PubMed ID: 38281867
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Biological actions of flavonoids].
    Spilková J; Hubík J
    Pharm Unserer Zeit; 1988 Jan; 17(1):1-9. PubMed ID: 3279429
    [No Abstract]   [Full Text] [Related]  

  • 77. The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs.
    Li Y; Paxton JW
    Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):267-85. PubMed ID: 23289831
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.
    Alvarez AI; Real R; Pérez M; Mendoza G; Prieto JG; Merino G
    J Pharm Sci; 2010 Feb; 99(2):598-617. PubMed ID: 19544374
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cardiac glycosides. Drug interactions of clinical significance.
    Magnani B; Malini PL
    Drug Saf; 1995 Feb; 12(2):97-109. PubMed ID: 7766341
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetic properties, potential herb-drug interactions and acute toxicity of oral Rhizoma coptidis alkaloids.
    Ma BL; Ma YM
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):51-61. PubMed ID: 22998215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.